{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,7,18]],"date-time":"2024-07-18T15:17:56Z","timestamp":1721315876533},"reference-count":12,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2019,4,1]],"date-time":"2019-04-01T00:00:00Z","timestamp":1554076800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.fr","clinicalkey.com.au","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Diabetes & Metabolism"],"published-print":{"date-parts":[[2019,4]]},"DOI":"10.1016\/j.diabet.2017.09.008","type":"journal-article","created":{"date-parts":[[2017,11,1]],"date-time":"2017-11-01T01:02:31Z","timestamp":1509498151000},"page":"201-204","update-policy":"http:\/\/dx.doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["Temporal characterization of cardiac expression of glucose transporters SGLT and GLUT in an experimental model of myocardial infarction"],"prefix":"10.1016","volume":"45","author":[{"given":"J.","family":"S\u00e1nchez-M\u00e1s","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"E.","family":"Saura-Guill\u00e9n","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.C.","family":"Asensio-L\u00f3pez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"\u00c1.","family":"Soriano-Filiu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"Carmen S\u00e1nchez-P\u00e9rez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.M.","family":"Hernandez-Martinez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.","family":"Lax","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"D.","family":"Pascual-Figal","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.diabet.2017.09.008_bib0065","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1002\/cphy.c150016","article-title":"Glucose transporters in cardiac metabolism and hypertrophy","volume":"6","author":"Shao","year":"2015","journal-title":"Compr Physiol"},{"key":"10.1016\/j.diabet.2017.09.008_bib0070","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1016\/S2213-8587(13)70050-0","article-title":"SGLT inhibitors in management of diabetes","volume":"1","author":"Tahrani","year":"2013","journal-title":"Lancet Diabetes Endocrinol"},{"key":"10.1016\/j.diabet.2017.09.008_bib0075","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1002\/jcb.10631","article-title":"Human cardiomyocytes express high level of Na+\/glucose cotransporter 1 (SGLT1)","volume":"90","author":"Zhou","year":"2003","journal-title":"J Cell Biochem"},{"key":"10.1016\/j.diabet.2017.09.008_bib0080","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1016\/j.ijcard.2016.12.083","article-title":"Glucose transporters in healthy heart and in cardiac disease","volume":"230","author":"Szablewski","year":"2017","journal-title":"Int J Cardiol"},{"key":"10.1016\/j.diabet.2017.09.008_bib0085","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1016\/j.bbrc.2016.02.016","article-title":"Inhibition of SGLT1 abrogates preconditioning-induced cardioprotection against ischemia-reperfusion injury","volume":"472","author":"Kanwal","year":"2016","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1016\/j.diabet.2017.09.008_bib0090","doi-asserted-by":"crossref","first-page":"1526","DOI":"10.1093\/eurheartj\/ehv728","article-title":"Heart failure outcomes with empagliflozin in patients with type 2 diabetes at high cardiovascular risk: results of the EMPA-REG OUTCOME trial","volume":"37","author":"Fitchett","year":"2016","journal-title":"Eur Heart J"},{"key":"10.1016\/j.diabet.2017.09.008_bib0095","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1093\/cvr\/cvp190","article-title":"SGLT1 is a novel cardiac glucose transporter that is perturbed in disease states","volume":"84","author":"Banerjee","year":"2009","journal-title":"Cardiovasc Res"},{"key":"10.1016\/j.diabet.2017.09.008_bib0100","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1016\/S0008-6363(01)00393-5","article-title":"Postinfarction heart failure in rats is associated with upregulation of GLUT-1 and downregulation of genes of fatty acid metabolism","volume":"52","author":"Rosenblatt-Velin","year":"2001","journal-title":"Cardiovasc Res"},{"key":"10.1016\/j.diabet.2017.09.008_bib0105","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1016\/j.jchf.2014.07.015","article-title":"Mineralocorticoid receptor antagonists modulate galectin-3 and interleukin-33\/ST2 signalling in left ventricular systolic dysfunction after acute myocardial infarction","volume":"3","author":"Lax","year":"2015","journal-title":"JACC Heart Fail"},{"key":"10.1016\/j.diabet.2017.09.008_bib0110","doi-asserted-by":"crossref","first-page":"746","DOI":"10.1113\/expphysiol.2012.070235","article-title":"Absence of glucose transporter 4 diminishes electrical activity of mouse hearts during hypoxia","volume":"98","author":"Sohn","year":"2013","journal-title":"Exp Physiol"},{"key":"10.1016\/j.diabet.2017.09.008_bib0115","doi-asserted-by":"crossref","first-page":"644","DOI":"10.1056\/NEJMoa1611925","article-title":"Canagliflozin and cardiovascular and renal events in Type 2 diabetes","volume":"377","author":"Mahaffey","year":"2017","journal-title":"N Engl J Med"},{"key":"10.1016\/j.diabet.2017.09.008_bib0120","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1016\/j.ijcard.2017.05.032","article-title":"Sodium-dependent glucose transporters (SGLT) in human ischemic heart: a new potential pharmacological target","volume":"243","author":"Di Franco","year":"2017","journal-title":"Int J Cardiol"}],"container-title":["Diabetes & Metabolism"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1262363617305207?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1262363617305207?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,8,21]],"date-time":"2019-08-21T21:50:49Z","timestamp":1566424249000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1262363617305207"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,4]]},"references-count":12,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2019,4]]}},"alternative-id":["S1262363617305207"],"URL":"https:\/\/doi.org\/10.1016\/j.diabet.2017.09.008","relation":{},"ISSN":["1262-3636"],"issn-type":[{"value":"1262-3636","type":"print"}],"subject":[],"published":{"date-parts":[[2019,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Temporal characterization of cardiac expression of glucose transporters SGLT and GLUT in an experimental model of myocardial infarction","name":"articletitle","label":"Article Title"},{"value":"Diabetes & Metabolism","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.diabet.2017.09.008","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Elsevier Masson SAS. All rights reserved.","name":"copyright","label":"Copyright"}]}}